i just see how it goes. it was an institutional placement at 8.5 as opposed to one to sophisticated investors. it is subject to shareholder approval which means no app 3b for a while. to my un trained eye, it looks like a good one.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025